Furthermore, the LSC assay is capable of quantitatively measuring the SIRPα-CD47 interaction in both live and fixed tumor cells; as a practical matter, this significantly reduces the cell culture burden and allows for the use of stable, fixed cell standards to control for inter- and intra-assay variations. Here, SIRPA is linked to neoplasm.